Clinical trial

A Long-term Safety Study of QVM149 in Japanese Patients With Asthma

NCT03100825

Study summary

ClinicalTrials.gov

A Long-term Safety Study of QVM149 in Japanese Patients With Asthma

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention QVM149 Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-04-28

PhasePHASE3

Conditions

Asthmaverified · MONDO: asthma

Interventions

QVM149DRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

SagamiharaKanagawa, Japan2 SapporoHokkaido, Japan1 YokohamaKanagawa, Japan1 OsakaOsaka, Japan1 SakaiOsaka, Japan1 HiroshimaHiroshima, Japan1 Ōta-kuTokyo, Japan1 MaebashiGunma, Japan1 TakamatsuKagawa-ken, Japan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03100825 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.